{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:14:17Z","timestamp":1787004857194,"version":"build-2736575974"},"reference-count":48,"publisher":"Georg Thieme Verlag KG","issue":"05","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacopsychiatry"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Introduction The variants of the gene for nitric oxide synthase 1 adaptor\n                    protein (NOS1AP) are associated with schizophrenia and cardiovascular\n                    deficits involving corrected QT (QTc) interval prolongation. Here, we\n                    investigated a possible pharmacogenetic effect of antipsychotic treatment on QTc\n                    length in interaction with two NOS1AP variants (rs12143842 and\n                    rs10494366) whose minor alleles are associated with increased QTc interval\n                    length.<\/jats:p>\n                  <jats:p>Methods We conducted a retrospective analysis of electrocardiographic\n                    (ECG) and genotype data of 239 patients diagnosed with schizophrenia. We\n                    converted antipsychotics dosage to chlorpromazine equivalents and defined daily\n                    doses. We analysed the effects of the minor (i.\u2009e.\n                    rs12143842-CT\/TT and rs10494366-GT\/GG) and major (i.\u2009e.\n                    rs12143842-CC and rs10494366-TT) allele genotypes to QTc interval for female and\n                    male participants separately.<\/jats:p>\n                  <jats:p>Results As expected, rs12143842 and rs10494366 exhibit strong linkage\n                    disequilibrium. Both polymorphisms had no direct effect on antipsychotic use or\n                    QTc interval. However, there was a continuous increase in QTc interval with\n                    increasing antipsychotic dosage in males. For both variants, positive\n                    correlation of QTc length with antipsychotic dosage was found in homozygous male\n                    carriers of the major alleles (i.\u2009e. rs12143842-CC and rs10494366-TT),\n                    but not in minor allele carriers. There was no significant interaction between\n                    antipsychotic dosage and QTc interval for either genotype in female\n                    patients.<\/jats:p>\n                  <jats:p>Conclusions In this study, a significant interaction was found between\n                    both NOS1AP variants, rs12143842 and rs10494366, and antipsychotic\n                    treatment on the QTc interval in a sex-dependent manner. Our findings might be\n                    relevant for adequate antipsychotic treatment in rs12143842 and rs10494366 major\n                    allele carriers.<\/jats:p>","DOI":"10.1055\/a-1811-7241","type":"journal-article","created":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T18:37:54Z","timestamp":1655923074000},"page":"266-273","source":"Crossref","is-referenced-by-count":8,"title":["Influence of NOS1AP Risk Variants on the Corrected QT (QTc)\n                    Interval in the Pharmacotherapy of Schizophrenia"],"prefix":"10.1055","volume":"55","author":[{"given":"Dilhan","family":"Esen","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Psychosomatic Medicine and Psychotherapy,\n                    University Hospital, Goethe University, Frankfurt, Germany"},{"name":"Faculty of Biological Sciences, Goethe-University, Frankfurt am Main,\n                    Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"Kopf","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Psychosomatic Medicine and Psychotherapy,\n                    University Hospital, Goethe University, Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"H\u00e4gele","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Psychosomatics and Psychotherapy, University\n                    Hospital W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Plichta","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Psychosomatic Medicine and Psychotherapy,\n                    University Hospital, Goethe University, Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Reif","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Psychosomatic Medicine and Psychotherapy,\n                    University Hospital, Goethe University, Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Freudenberg","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Psychosomatic Medicine and Psychotherapy,\n                    University Hospital, Goethe University, Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2022,6,22]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.jpsychires.2013.07.011","article-title":"Schizophrenia and the risk of cardiovascular diseases: A meta-analysis of\n                    thirteen cohort studies","volume":"47","author":"Z Fan","year":"2013","journal-title":"J Psychiatr Res"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1001\/jamapsychiatry.2015.1737","article-title":"Premature mortality among adults with schizophrenia in the United States","volume":"72","author":"M Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1017\/S2045796017000166","article-title":"Increased cardiovascular mortality in people with schizophrenia: A 24-year\n                    national register study","volume":"27","author":"J Westman","year":"2018","journal-title":"Epidemiol Psychiatr Sci"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1139\/jpn.0550","article-title":"Cardiac risk and schizophrenia","volume":"30","author":"R Jindal","year":"2005","journal-title":"J Psychiatry Neurosci"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1185\/03007995.2013.840568","article-title":"QT interval prolongation and the risk of torsades de pointes: Essentials for\n                    clinicians","volume":"29","author":"K E Trinkley","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s11920-008-0027-0","article-title":"NOS1AP in schizophrenia","volume":"10","author":"L M Brzustowicz","year":"2008","journal-title":"Curr Psychiatry Rep"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/gbb.12193","article-title":"Neuronal nitric oxide synthase (NOS1) and its adaptor, NOS1AP, as a genetic risk\n                    factors for psychiatric disorders","volume":"14","author":"F Freudenberg","year":"2015","journal-title":"Genes Brain Behav"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1371\/journal.pmed.0020263","article-title":"Increased expression in dorsolateral prefrontal cortex of CAPON in schizophrenia\n                    and bipolar disorder","volume":"2","author":"B Xu","year":"2005","journal-title":"PLoS Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2010.05.009","article-title":"NOS1AP protein levels are altered in BA46 and cerebellum of patients with\n                    schizophrenia","author":"N M Hadzimichalis","year":"2010","journal-title":"Schizophr Res"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1176\/appi.ajp.2011.10050723","article-title":"Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the\n                    consortium on the genetics of schizophrenia","volume":"168","author":"T A Greenwood","year":"2011","journal-title":"Am J Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/hmg\/ddn341","article-title":"Identification of a common variant at the NOS1AP locus strongly associated to\n                    QT-interval duration","volume":"18","author":"M Eijgelsheim","year":"2009","journal-title":"Hum Mol Genet"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.2337\/db07-1365","article-title":"Association of NOS1AP genetic variants with QT interval duration in families\n                    from the Diabetes Heart Study. Diabetes","volume":"57","author":"A B Lehtinen","year":"2008"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1093\/ije\/dyn091","article-title":"Gender and effects of a common genetic variant in the NOS1 regulator NOS1AP on\n                    cardiac repolarization in 3761 individuals from two independent populations","volume":"37","author":"M D Tobin","year":"2008","journal-title":"Int J Epidemiol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1161\/CIRCULATIONAHA.106.676783","article-title":"Common NOS1AP variants are associated with a prolonged QTc interval in the\n                    Rotterdam Study","volume":"116","author":"AJLH J Aarnoudse","year":"2007","journal-title":"Circulation"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1159\/000103630","article-title":"Associations between genetic variants in the NOS1AP (CAPON) gene and\n                    cardiac repolarization in the Old Order Amish","volume":"64","author":"W Post","year":"2007","journal-title":"Hum Hered"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/ng1790","article-title":"A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac\n                    repolarization","volume":"38","author":"D E Arking","year":"2006","journal-title":"Nat Genet"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.1073\/pnas.0709118105","article-title":"CAPON modulates cardiac repolarization via neuronal nitric oxide synthase\n                    signaling in the heart","volume":"105","author":"K-C Chang","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1111\/JCE.12827","article-title":"NOS1AP polymorphisms modify QTc interval duration but not cardiac arrest risk in\n                    hypertrophic cardiomyopathy","volume":"26","author":"N Earle","year":"2015","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psym.2012.11.001","article-title":"QTc prolongation, torsades de pointes, and psychotropic medications","volume":"54","author":"S R Beach","year":"2013","journal-title":"Psychosomatics"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2165\/00002018-200023030-00004","article-title":"Cardiovascular adverse effects of antipsychotic drugs","volume":"23","author":"N A Buckley","year":"2000","journal-title":"Drug Saf"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/TPJ.2010.76","article-title":"Genome-wide association study of antipsychotic-induced QTc interval\n                    prolongation","volume":"12","author":"K \u00c5berg","year":"2012","journal-title":"Pharmacogenomics J"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The Genotype-Tissue Expression (GTEx) project","volume":"45","author":"J Lonsdale","year":"2013","journal-title":"Nat Genet"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jacc.2008.12.014","article-title":"AHA\/ACCF\/HRS Recommendations for the standardization and\n                    interpretation of the electrocardiogram. Part IV: The ST segment, T and U waves,\n                    and the QT interval A scientific statement from the American Heart Association\n                    Electrocardiography and Arrhythmias Co","volume":"53","author":"P M Rautaharju","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"ref24","first-page":"353","article-title":"An analysis of the time-relations of electrocardiograms","volume":"7","author":"H C Bazett","year":"1920","journal-title":"Heart"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0002-9149(99)80603-1","article-title":"The missing second: What is the correct unit for the Bazett corrected Qt\n                    interval?","volume":"75","author":"J Molnar","year":"1995","journal-title":"Am J Cardiol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1176\/appi.ajp.2009.09060802","article-title":"International consensus study of antipsychotic dosing","volume":"167","author":"D M Gardner","year":"2010","journal-title":"Am J Psychiatry"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"S90","DOI":"10.1093\/schbul\/sbv167","article-title":"Dose equivalents for antipsychotic drugs: The DDD method","volume":"42","author":"S Leucht","year":"2016","journal-title":"Schizophr Bull"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"H640","DOI":"10.1152\/ajpheart.00864.2013","article-title":"Sex differences in the mechanisms underlying long QT syndrome","volume":"307","author":"G Salama","year":"2014","journal-title":"Am J Physiol \u2013 Hear Circ Physiol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e98555","DOI":"10.1371\/journal.pone.0098555","article-title":"QT is longer in drug-free patients with schizophrenia compared with age-matched\n                    healthy Subjects","volume":"9","author":"K Fujii","year":"2014","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1093\/bioinformatics\/btv402","article-title":"LDlink: A web-based application for exploring population-specific haplotype\n                    structure and linking correlated alleles of possible functional variants","volume":"31","author":"M J Machiela","year":"2015","journal-title":"Bioinformatics"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1136\/postgradmedj-2020-138661","article-title":"Managing drug-induced QT prolongation in clinical practice","volume":"97","author":"R Khatib","year":"2021","journal-title":"Postgrad Med J"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.2165\/00003495-200262110-00006","article-title":"Antipsychotic-related QTc prolongation, torsade de pointes and sudden death","volume":"62","author":"P M Haddad","year":"2002","journal-title":"Drugs"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1177\/02698811211003477","article-title":"Antipsychotics in routine treatment are minor contributors to QT prolongation\n                    compared to genetics and age","volume":"35","author":"L Hommers","year":"2021","journal-title":"J Psychopharmacol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/clc.20208","article-title":"Assessment of QT intervals and prevalence of short QT syndrome in Japan","volume":"31","author":"A Funada","year":"2008","journal-title":"Clin Cardiol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jelectrocard.2006.09.003","article-title":"Electrocardiographic reference ranges derived from 79,743 ambulatory\n                    subjects","volume":"40","author":"J W Mason","year":"2007","journal-title":"J Electrocardiol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00213-011-2188-5","article-title":"Sex difference in QTc prolongation in chronic institutionalized patients with\n                    schizophrenia on long-term treatment with typical and atypical\n                    antipsychotics","volume":"216","author":"FDe Yang","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/J.0065-1591.2000.0AP25.X","article-title":"Sex differences in schizophrenia, a review of the literature","volume":"401","author":"A Leung","year":"2000","journal-title":"Acta Psychiatr Scand"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3389\/FPSYT.2021.650904\/BIBTEX","article-title":"The pharmacodynamics of antipsychotic drugs in women and men","volume":"12","author":"M V Seeman","year":"2021","journal-title":"Front Psychiatry"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/J.SCHRES.2009.09.041","article-title":"QTc interval in a sample of long-term schizophrenia inpatients","volume":"116","author":"R Ramos-R\u00edos","year":"2010","journal-title":"Schizophr Res"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/01.jcp.0000096247.29231.3a","article-title":"Chlorpromazine equivalents versus defined daily doses: How to compare\n                    antipsychotic drug doses?","volume":"23","author":"CA W Rijcken","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/YIC.0b013e328303ac75","article-title":"Is the defined daily dose system a reliable tool for standardizing antipsychotic\n                    dosages?","volume":"23","author":"M Nos\u00e8","year":"2008","journal-title":"Int Clin Psychopharmacol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/J.1552-4604.1994.TB01995.X","article-title":"Clinical pharmacokinetics of antipsychotics","volume":"34","author":"J I Javaid","year":"1994","journal-title":"J Clin Pharmacol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3390\/JCM10184275","article-title":"Review: Influence of the CYP450 genetic variation on the treatment of psychotic\n                    disorders","volume":"10","author":"L Carrascal-Laso","year":"2021","journal-title":"J Clin Med"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/S11096-016-0414-2","article-title":"Risk factors for QTc-prolongation: Systematic review of the evidence","volume":"39","author":"E Vandael","year":"2017","journal-title":"Int J Clin Pharm"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1089\/JWH.2011.3444","article-title":"Sex hormones and the QT interval: A review","volume":"21","author":"T Sedlak","year":"2012","journal-title":"J Women\u2019s Heal"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1186\/1744-859X-4-1","article-title":"QT interval prolongation related to psychoactive drug treatment: A comparison of\n                    monotherapy versus polytherapy","volume":"4","author":"M Sala","year":"2005","journal-title":"Ann Gen Psychiatry"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1017\/S1092852917000402","article-title":"QTc interval in patients with schizophrenia receiving antipsychotic treatment as\n                    monotherapy or polypharmacy","volume":"23","author":"A Elliott","year":"2018","journal-title":"CNS Spectr"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1177\/2045125317721662","article-title":"Combinations of QTc-prolonging drugs: Towards disentangling pharmacokinetic and\n                    pharmacodynamic effects in their potentially additive nature","volume":"7","author":"A D Meid","year":"2017","journal-title":"Ther Adv Psychopharmacol"}],"container-title":["Pharmacopsychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1811-7241.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T00:26:03Z","timestamp":1763166363000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1811-7241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,22]]},"references-count":48,"journal-issue":{"issue":"05","published-online":{"date-parts":[[2022,9,8]]},"published-print":{"date-parts":[[2022,9]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1811-7241","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0176-3679","1439-0795"],"issn-type":[{"value":"0176-3679","type":"print"},{"value":"1439-0795","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,22]]}}}